Aspiriant LLC’s Microsoft MSFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7M Sell
42,289
-5,797
-12% -$2.43M 0.45% 32
2025
Q4
$23.3M Buy
48,086
+3,092
+7% +$1.55M 0.67% 25
2025
Q3
$23.3M Sell
44,994
-1,953
-4% -$996K 0.71% 24
2025
Q2
$23.4M Sell
46,947
-54
-0.1% -$23.5K 0.74% 23
2025
Q1
$17.6M Buy
47,001
+187
+0.4% +$76.2K 0.61% 26
2024
Q4
$19.7M Buy
46,814
+1,086
+2% +$463K 0.71% 20
2024
Q3
$19.7M Sell
45,728
-17
-0% -$7.27K 0.75% 24
2024
Q2
$20.4M Sell
45,745
-3,298
-7% -$1.39M 0.83% 21
2024
Q1
$20.6M Sell
49,043
-312
-0.6% -$126K 0.85% 21
2023
Q4
$18.6M Sell
49,355
-377
-0.8% -$134K 0.84% 22
2023
Q3
$15.7M Buy
49,732
+1,456
+3% +$481K 0.8% 22
2023
Q2
$16.4M Buy
48,276
+1,834
+4% +$575K 0.83% 22
2023
Q1
$13.4M Sell
46,442
-708
-2% -$181K 0.7% 24
2022
Q4
$11.3M Sell
47,150
-2,109
-4% -$506K 0.58% 29
2022
Q3
$11.5M Buy
49,259
+3,082
+7% +$814K 0.56% 28
2022
Q2
$11.9M Buy
46,177
+165
+0.4% +$44.8K 0.57% 27
2022
Q1
$14.2M Sell
46,012
-10,465
-19% -$3.15M 0.78% 21
2021
Q4
$19M Buy
56,477
+13,488
+31% +$4.37M 1.02% 18
2021
Q3
$12.1M Sell
42,989
-947
-2% -$276K 0.71% 22
2021
Q2
$11.9M Buy
43,936
+739
+2% +$188K 0.67% 23
2021
Q1
$10.2M Buy
43,197
+1,218
+3% +$283K 0.65% 24
2020
Q4
$9.34M Sell
41,979
-35,125
-46% -$7.55M 0.64% 23
2020
Q3
$16.2M Buy
77,104
+33,843
+78% +$7.11M 1.27% 15
2020
Q2
$8.8M Sell
43,261
-679
-2% -$123K 0.82% 22
2020
Q1
$6.93M Sell
43,940
-3,445
-7% -$567K 0.68% 26
2019
Q4
$7.48M Sell
47,385
-615
-1% -$90.3K 0.69% 28
2019
Q3
$6.68M Sell
48,000
-643
-1% -$88.4K 0.6% 31
2019
Q2
$6.52M Sell
48,643
-2,271
-4% -$288K 0.54% 37
2019
Q1
$6M Sell
50,914
-2,130
-4% -$232K 0.49% 39
2018
Q4
$5.39M Sell
53,044
-636
-1% -$68.1K 0.41% 41
2018
Q3
$6.13M Sell
53,680
-2,167
-4% -$235K 0.52% 35
2018
Q2
$5.51M Buy
55,847
+5,281
+10% +$512K 0.47% 44
2018
Q1
$4.62M Buy
50,566
+43,883
+657% +$4.01M 0.4% 47
2017
Q4
$572K Sell
6,683
-41,013
-86% -$3.36M 0.17% 46
2017
Q3
$3.55M Buy
47,696
+1,341
+3% +$98K 0.3% 50
2017
Q2
$3.19M Buy
46,355
+8,458
+22% +$581K 0.28% 56
2017
Q1
$2.5M Buy
37,897
+3,728
+11% +$239K 0.21% 75
2016
Q4
$2.12M Sell
34,169
-661
-2% -$39.8K 0.19% 69
2016
Q3
$2.01M Sell
34,830
-6,326
-15% -$357K 0.2% 70
2016
Q2
$1.88M Buy
41,156
+7,983
+24% +$415K 0.18% 78
2016
Q1
$1.83M Buy
33,173
+24,562
+285% +$1.29M 0.17% 73
2015
Q4
$478K Buy
8,611
+2,246
+35% +$118K 0.05% 57
2015
Q3
$282K Sell
6,365
-10,259
-62% -$461K 0.02% 86
2015
Q2
$734K Sell
16,624
-4,566
-22% -$208K 0.07% 58
2015
Q1
$861K Buy
21,190
+1,500
+8% +$65.3K 0.11% 44
2014
Q4
$915K Buy
19,690
+10,400
+112% +$488K 0.12% 42
2014
Q3
$431K Buy
9,290
+300
+3% +$13.4K 0.06% 64
2014
Q2
$375K Buy
+8,990
New +$364K 0.05% 70

Other funds holding MSFT

Aspiriant LLC's MSFT Position: Q1 2026 in Review

Aspiriant LLC reduced its Microsoft (MSFT) stake by 12% in Q1 2026, selling an estimated $2.43M and leaving 42,289 shares worth $15.7M. The position accounts for 0.45% of the portfolio, ranked #32.

Aspiriant LLC first reported a position in MSFT in Q2 2014 and has held it in 48 quarters since. The position peaked at $23.4M in Q2 2025. 6,179 funds tracked by Wall St. Rank hold MSFT as of Q1 2026.

  • Aspiriant LLC held 42,289 shares of Microsoft worth $15.7M as of Q1 2026.
  • Aspiriant LLC sold 5,797 Microsoft shares in Q1 2026, an estimated $2.43M.
  • Microsoft made up 0.45% of Aspiriant LLC's portfolio in Q1 2026, its #32 holding.
  • Aspiriant LLC first reported a position in Microsoft in Q2 2014 and has held it in 48 quarters since.
  • Aspiriant LLC's Microsoft position peaked at $23.4M in Q2 2025.
  • 6,179 funds tracked by Wall St. Rank held Microsoft as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.